Published in Am J Cardiol on September 04, 1997
International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood (1997) 20.41
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med (1997) 6.19
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ (1998) 6.07
A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med (1999) 5.14
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med (1996) 4.70
Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J (1989) 4.62
Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects. Gut (1965) 4.56
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med (2001) 4.33
Trehalose synthesis genes are controlled by the putative sigma factor encoded by rpoS and are involved in stationary-phase thermotolerance in Escherichia coli. J Bacteriol (1991) 4.15
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med (1996) 4.10
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet (2001) 3.69
Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J (2002) 3.56
[CBO guideline 'Deep venous thrombosis and pulmonary embolism; revision of the earlier guidelines. Dutch Organization for Quality Assurance in Hospitals]. Ned Tijdschr Geneeskd (2000) 3.32
Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med (1982) 3.16
Guidelines for management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. Consensus Conference on Prosthetic Valve Thrombosis. J Am Coll Cardiol (1997) 3.06
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet (1989) 2.97
Coronary thrombolysis with intravenous anisoylated plasminogen-streptokinase complex BRL 26921. Br Heart J (1985) 2.92
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med (2001) 2.54
Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49
Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure. Eur Heart J (2000) 2.45
A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med (1993) 2.39
Long-lasting sport practice and lone atrial fibrillation. Eur Heart J (2002) 2.26
Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J (2003) 2.20
Cardiac troponin T. Lancet (1993) 2.13
Reversal by ceftriaxone of dilated cardiomyopathy Borrelia burgdorferi infection. Lancet (1992) 2.08
Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist. Clin Pharmacol Ther (1999) 2.06
The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study. Epidemiol Infect (1993) 2.00
Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. Cancer Res (2001) 1.94
Trehalose transport and metabolism in Escherichia coli. J Bacteriol (1990) 1.92
Clinical trial of deglycyrrhizinized liquorice in gastric ulcer. Gut (1969) 1.88
Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc Natl Acad Sci U S A (1997) 1.88
Idiopathic gangrene in African children. Br Med J (1967) 1.85
Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med (1991) 1.81
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia (2009) 1.80
Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study. N Engl J Med (1982) 1.79
High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr (1991) 1.78
The genetic determination of left ventricular mass in healthy adults. Eur Heart J (2003) 1.77
Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker. Br Heart J (1988) 1.75
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology (1988) 1.74
An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg (2001) 1.72
Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J (1998) 1.71
[Clinical judgment and decision in practice. A patient with dyspnea]. Ned Tijdschr Geneeskd (1996) 1.71
[Clinical thinking and judgment in clinical practice. A patient with diarrhea]. Ned Tijdschr Geneeskd (1996) 1.71
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med (1986) 1.67
Combined use of leg scanning and impedance plethysmography in suspected venous thrombosis. An alternative to venography. N Engl J Med (1977) 1.66
Humoral and cellular immune responses up to 7.5 years after administration of streptokinase for acute myocardial infarction. Eur Heart J (1999) 1.64
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res (1998) 1.63
Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol (1997) 1.60
Central corneal thickness determined with optical coherence tomography in various types of glaucoma. Br J Ophthalmol (2000) 1.58
Self-organization in leaky threshold systems: the influence of near-mean field dynamics and its implications for earthquakes, neurobiology, and forecasting. Proc Natl Acad Sci U S A (2002) 1.57
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group. J Clin Oncol (2000) 1.53
Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med (1983) 1.51
Transfusion-requiring haemolytic anaemia after mitral-valve repair. Lancet (1996) 1.51
Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol (2001) 1.51
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49
Perforated ventricular aneurysm in a male suffering from pneumonia. Clin Cardiol (1991) 1.48
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation (1997) 1.47
Exaggerated initial response to warfarin following heart valve replacement. Am J Cardiol (1999) 1.47
Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty. Eur J Clin Invest (1999) 1.47
From food-dependent statistics to metabolic parameters, a practical guide to the use of dynamic energy budget theory. Biol Rev Camb Philos Soc (2008) 1.46
Nonlinear network dynamics on earthquake fault systems. Phys Rev Lett (2001) 1.46
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. J Thromb Haemost (2007) 1.44
Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost (1995) 1.44
[Incidental gallbladder carcinoma--a report of experiences after 1,200 laparoscopic cholecystectomies]. Zentralbl Chir (1997) 1.42
Acute and mid-term combined hormone replacement therapy improves endothelial function in post-menopausal women with angina and angiographically normal coronary arteries. Eur Heart J (2001) 1.41
Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins. Diabetologia (1984) 1.41
Effects of nadolol on arrhythmias during laparoscopy performed under general anaesthesia. Br J Anaesth (1988) 1.41
Feasibility and prognostic value of dobutamine-atropine stress echocardiography early in unstable angina. Eur Heart J (2000) 1.41
Assessment by general practitioners of suitability of thrombolysis in patients with suspected acute myocardial infarction. Br Heart J (1993) 1.40
[Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia]. Ned Tijdschr Geneeskd (2002) 1.40
Abnormal epidermal changes after argon laser treatment. J Am Acad Dermatol (1991) 1.40
Seven coronary angioplasties of the left circumflex artery in a 68-year-old male. Eur Heart J (1994) 1.40
Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age. Thromb Haemost (1995) 1.40
[Clinical judgment and decision making. A patient with tetany]. Ned Tijdschr Geneeskd (1996) 1.40
Impaired response of atrial natriuretic factor to blood volume expansion in acute right ventricular infarction. Am J Cardiol (1991) 1.40
Severe intra-abdominal bleeding following stapled mucosectomy due to enterocele: report of a case. Tech Coloproctol (2004) 1.40
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia (2004) 1.39
[Improvement in the treatment of acute myocardial infarct by the establishment of a thrombolysis unit in a cardiology servic]. Rev Esp Cardiol (1998) 1.39
Minimal effects of levosimendan on coronary artery smooth muscle tone. Cardiovasc Drugs Ther (1999) 1.39
[Deep venous thrombosis: does recently improved knowledge lead to a real advance in the direction patient care?]. Ned Tijdschr Geneeskd (1996) 1.39
Is the antiproteinuric effect of dipyridamole hemodynamically mediated? Nephron (1988) 1.39
Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer (2006) 1.39
[Quality assurance in bariatric surgery in Germany--results of the German multicentre trial 2005 and 2006]. Zentralbl Chir (2008) 1.38
[Are there still indications for plasma transfusions?]. Ned Tijdschr Geneeskd (1991) 1.37
A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest (1990) 1.32
Deep prosthesis infection in incisional hernia repair: predictive factors and clinical outcome. Eur J Surg (2001) 1.31
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut (2005) 1.30